| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 21, 2025 | Aug 22, 2025 | ARS Pharmaceuticals, Inc. | CFO | Sell | 10.0 | -12,500 | -40.59% | ✓ | $187.5K |
| May 20, 2025 | May 22, 2025 | ARS Pharmaceuticals, Inc. | CFO | Sell | 20.0 | -50,000 | -76.13% | ✗ | $705.2K |
| Oct 16, 2024 | Oct 17, 2024 | ARS Pharmaceuticals, Inc. | CFO | Sell | 10.0 | -12,500 | -48.64% | ✓ | $200K |
| Aug 20, 2024 | Aug 21, 2024 | ARS Pharmaceuticals, Inc. | CFO | Sell | 10.0 | -12,500 | -48.64% | ✓ | $200K |
| Nov 29, 2022 | Dec 1, 2022 | ARS Pharmaceuticals, Inc. | CFO | Buy | 95.0 | +8,250 | 100.00% | ✗ | $51.5K |